Cited by 206Bone health and osteoporosis researchRenal Diseases and GlomerulopathiesGrowth Hormone and Insulin-like Growth Factors

Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome

Open access
Leonard, Mary B., Feldman, Harold I., Shults, Justine, Zemel, Babette S., Foster, Bethany J., Stallings, Virginia A.·2004·New England Journal of Medicine

Abstract

BACKGROUND: Glucocorticoids suppress bone formation, impair growth, and induce obesity. We determined the effects of long-term treatment with glucocorticoids on bone mineral content in children with glucocorticoid-sensitive nephrotic syndrome, a disorder with minimal known independent effects on bone. METHODS: We performed dual-energy x-ray absorptiometry of the whole body and spine in 60 children and adolescents with the nephrotic syndrome and 195 control subjects. We used linear regression analysis of log-transformed values to compare the bone mineral content in patients with that in controls. RESULTS: Patients had received an average of 23,000 mg of glucocorticoids and were shorter (P=0.008) and had a greater body-mass index (P<0.001) than controls. The bone mineral content of the spine, adjusted for bone area, age, sex, degree of maturation (Tanner stage), and race, did not differ significantly between patients and controls (ratio, 0.99; 95 percent confidence interval, 0.96 to 1.02; P=0.51). After adjustment for the z score for body-mass index, the bone mineral content of the spine was significantly lower in patients than in controls (0.96; 95 percent confidence interval, 0.92 to 0.99; P=0.01). Whole-body bone mineral content, adjusted for height, age, sex, degree of maturation, and race, was significantly higher in patients than in controls (ratio, 1.11; 95 percent confidence interval, 1.05 to 1.18; P<0.001); however, the addition of the z score for body-mass index to the model eliminated the association with the nephrotic syndrome (ratio, 0.99; 95 percent confidence interval, 0.94 to 1.03; P=0.55). CONCLUSIONS: Intermittent treatment with high-dose glucocorticoids during growth does not appear to be associated with deficits in the bone mineral content of the spine or whole body relative to age, bone size, sex, and degree of maturation. Glucocorticoid-induced increases in body-mass index were associated with increased whole-body bone mineral content and maintenance of the bone mineral content of the spine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa040367

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Glucocorticoid-induced bone changes in children are usually confounded by the underlying disease and the changes in body mass.

    “Glucocorticoid-induced bone changes in children are usually confounded by the underlying disease and the changes in body mass [6, 7, 33].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF. A new model for the regulation of bone resorption, with particu- lar reference to the effects of bisphospho- nates. J Bone Miner Res 1996;11:150-9.
  2. The primary nephrotic syndrome in children: identification of patients with min- imal change nephrotic syndrome from ini- tial response to prednisone: a report of the International Study of Kidney Disease in Chil- dren. J Pediatr 1981;98:561-4.
  3. Tanner JM. Growth at adolescence. 2nd ed. Oxford, England: Blackwell Scientific, 1962.
  4. Landin LA. Epidemiology of children's fractures. J Pediatr Orthop B 1997;6:79-83.

Cited by

Sorted by citations

Authors
Leonard, M. B., Feldman, H. I., Shults, J., Zemel, B. S., Foster, B. J., & Stallings, V. A.
Affiliations
  • Children's Hospital of Philadelphia (US)
  • University of Pennsylvania (US)
Venue
New England Journal of Medicine
Published
2004-08-26
Volume
351
Issue
9
Pages
868-875
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2095291466
Cited by
206
References
37
Citations by year
2026: 2 · 2025: 5 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 6 · 2019: 11 · 2018: 2 · 2017: 11 · 2016: 11 · 2015: 10 · 2014: 16 · 2013: 15 · 2012: 5
FWCI
19.13
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (7k08dk002523-07, 7r03dk058200-02)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K08-DK02523, T32DK007785, 1-R03-DK058200)
  • National Center for Research Resources (M01-RR-00240, M01RR000240)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
glucocorticoids, nephrotic syndrome, bone mineral content, childhood, high-dose glucocorticoid therapy, body mass index, growth, obesity, bone mineral density, spine
MeSH terms
Adolescent, Body Height, Child, Glucocorticoids, Growth, Humans, Lumbar Vertebrae, Nephrotic Syndrome, Prednisone, Absorptiometry, Photon, Bone Density, Body Mass Index, Linear Models, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review